iTeos Therapeutics, Inc.
Industry: Life Sciences ・ $ITOS on Nasdaq
Insider Purchase
+$38,650
+8.27%
Shares
Shares Volume: 5,000 Shares
Average Share Price: $7.73
INSIDER
Gall Matthew
Chief Financial Officer (Officer)
reported on Nov 19 2024
traded on Nov 19 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 65,429 |
| PURCHASES/SALES 1Y | 1 / 0 |
| P/S VALUE RATIO | n/a |
| AVERAGE PURCHASE VALUE | $38,650 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 0 |
| PURCHASES/SALES 1Y | 1 / 0 |
| P/S VALUE RATIO | n/a |
| AVERAGE PURCHASE VALUE | $38,650 |
| COMPANY PREVIOUS TRADES | No trades in past 1Y |